It was reported that treatment with sitagliptin (250 mg/kg, 2 weeks, PO) significantly revealed an anti-apoptotic effect by reducing caspase-3 amount in the hippocampus of diabetic rats with cerebral ischemia/reperfusion injury (19). Here, CASP3 is linked to brain ischemia.